77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC)
Main Authors: | , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-11-01
|
Series: | Journal for ImmunoTherapy of Cancer |
id |
doaj-535c95318305473282560c0ef50dded5 |
---|---|
record_format |
Article |
spelling |
doaj-535c95318305473282560c0ef50dded52020-12-11T10:05:07ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262020-11-018Suppl 310.1136/jitc-2020-SITC2020.007777 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC)Yun Zhang0Xin Li1Hongming Pan2Yoon-Koo Kang3Chia-Jui Yen4Ming-Mo Hou5Kun-Ming Rau6Ying Yuan7Xiaopeng Ma8Xikun Wu9Jong-Seok Lee10Cunjing Yu11Katie Wood121 Clinical Medicine Department, Fujian Health College, Fuzhou, China 2 Department of Rheumatology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, Liaoning, China Aff4 0000 0004 1759 700Xgrid.13402.34Sir Run Run Shaw Hospital, College of MedicineZhejiang University Hangzhou China Aff6 0000 0004 0533 4667grid.267370.7Asan Medical CenterUniversity of Ulsan College of Medicine Seoul South Korea 5 National Cheng Kung University Hospital, Tainan, Taiwan 9 Chang Gung Memorial Hospital, Chang Gung University, Linkou, Taiwan 13 Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan 4 The Cancer Institute Key Laboratory of Cancer Prevention and Intervention, Chinese National Ministry of Education, The Second Affiliated Hospital Zhejiang University School of Medicine, Zhejiang, China 7Beigene (Beijing) Co., Ltd., Beijing, China6Beigene (Shanghai) Co., Ltd., Shanghai, China4National University Bundang Hospital, Seongnam-si, Korea, Republic of7BeiGene (Beijing) Co., Ltd., Beijing, China8BeiGene USA, Inc., San Mateo, CA, USA |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Yun Zhang Xin Li Hongming Pan Yoon-Koo Kang Chia-Jui Yen Ming-Mo Hou Kun-Ming Rau Ying Yuan Xiaopeng Ma Xikun Wu Jong-Seok Lee Cunjing Yu Katie Wood |
spellingShingle |
Yun Zhang Xin Li Hongming Pan Yoon-Koo Kang Chia-Jui Yen Ming-Mo Hou Kun-Ming Rau Ying Yuan Xiaopeng Ma Xikun Wu Jong-Seok Lee Cunjing Yu Katie Wood 77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) Journal for ImmunoTherapy of Cancer |
author_facet |
Yun Zhang Xin Li Hongming Pan Yoon-Koo Kang Chia-Jui Yen Ming-Mo Hou Kun-Ming Rau Ying Yuan Xiaopeng Ma Xikun Wu Jong-Seok Lee Cunjing Yu Katie Wood |
author_sort |
Yun Zhang |
title |
77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) |
title_short |
77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) |
title_full |
77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) |
title_fullStr |
77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) |
title_full_unstemmed |
77 Association between programmed death-ligand 1 (PD-L1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (HCC) |
title_sort |
77 association between programmed death-ligand 1 (pd-l1) expression and gene signatures of response or resistance to tislelizumab monotherapy in hepatocellular carcinoma (hcc) |
publisher |
BMJ Publishing Group |
series |
Journal for ImmunoTherapy of Cancer |
issn |
2051-1426 |
publishDate |
2020-11-01 |
work_keys_str_mv |
AT yunzhang 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT xinli 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT hongmingpan 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT yoonkookang 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT chiajuiyen 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT mingmohou 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT kunmingrau 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT yingyuan 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT xiaopengma 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT xikunwu 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT jongseoklee 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT cunjingyu 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc AT katiewood 77associationbetweenprogrammeddeathligand1pdl1expressionandgenesignaturesofresponseorresistancetotislelizumabmonotherapyinhepatocellularcarcinomahcc |
_version_ |
1724386446594277376 |